Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan vs Atenolol Sexual Function Study
NCT00541684Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2001
- Primary completion
- Jan 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of losartan in hypertension (HTN) (2 arms), sponsored by Organon & Co. Primary endpoint: Number of sexual intercourse events in a 2-week period at 16 weeks. Started Jul 2001; status: completed.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00541684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541684.